Article Details

Roth Capital Reiterates "Buy" Rating for Mind Medicine (MindMed) (NASDAQ:MNMD)

Retrieved on: 2022-12-09 17:24:55

Tags for this article:

Click the tags to see associated articles and topics

Roth Capital Reiterates "Buy" Rating for Mind Medicine (MindMed) (NASDAQ:MNMD). View article details on hiswai:

Excerpt

Millennium Management LLC now owns 5,075,110 shares of the company's stock worth $3,249,000 after acquiring an additional 4,638,774 shares during the ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up